We are live on ! Find out more
CLPT icon

ClearPoint Neuro
CLPT

69 hedge funds and large institutions have $97.5M invested in ClearPoint Neuro in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $4.34M | Put options by funds: $2.99M

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

4% less capital invested

Capital invested by funds: $102M → $97.5M (-$4.58M)

1.29% less ownership

Funds ownership: 25.82% → 24.53% (-1.3%)

9% less funds holding

Funds holding: 76 → 69 (-7)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
24
Reduced
19
Closed
17
Calls
$4.34M
Puts
$2.99M
Net Calls
+$1.34M
Net Calls Change
-$286K

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$9.82M
2
GPC
Guardian Point Capital
Virginia
+$4.31M
3
FAM
Fred Alger Management
New York
+$3.57M
4
Goldman Sachs
Goldman Sachs
New York
+$1.21M
5
Wells Fargo
Wells Fargo
California
+$871K

Top Sellers

Rank Fund Capital Flow
1
PGM
Parian Global Management
New York
-$9.85M
2
KC
Kepos Capital
New York
-$1.41M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.08M
4
Millennium Management
Millennium Management
New York
-$974K
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$921K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCWM
51
Total Clarity Wealth Management
Illinois
$166K +$175K +9,350 New
EVM
52
Eaton Vance Management
Massachusetts
$138K – – –
MIM
53
MetLife Investment Management
New Jersey
$137K – – –
SG Americas Securities
54
SG Americas Securities
New York
$115K +$121K +6,479 New
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
$105K – – –
Citigroup
56
Citigroup
New York
$40K +$25.8K +1,376 +154%
MFT
57
Moisand Fitzgerald Tamayo
Florida
$39K -$40.5K -2,161 -49%
PNC Financial Services Group
58
PNC Financial Services Group
Pennsylvania
$36K – – –
Legal & General Group
59
Legal & General Group
United Kingdom
$35K – – –
AIP
60
Ameritas Investment Partners
Nebraska
$26K – – –
TRCT
61
Tower Research Capital (TRC)
New York
$12K +$8.44K +450 +174%
Osaic Holdings
62
Osaic Holdings
Arizona
$8K -$975 -52 -10%
GAM
63
Gemmer Asset Management
California
$3K – – –
GI
64
Gradient Investments
Minnesota
$3K – – –
HI
65
Harbour Investments
Wisconsin
$2K – – –
CG
66
Cutler Group
California
$1K – – –
Fifth Third Bancorp
67
Fifth Third Bancorp
Ohio
$1K – – –
GEA
68
Glen Eagle Advisors
New Jersey
$888 +$938 +50 New
Marshall Wace
69
Marshall Wace
United Kingdom
– -$1.08M -56,391 Closed
Millennium Management
70
Millennium Management
New York
– -$974K -51,020 Closed
Assenagon Asset Management
71
Assenagon Asset Management
Luxembourg
– -$921K -48,255 Closed
Renaissance Technologies
72
Renaissance Technologies
New York
– -$911K -47,700 Closed
TCM
73
Triumph Capital Management
Colorado
– -$500K -29,509 Closed
Stifel Financial
74
Stifel Financial
Missouri
– -$477K -25,000 Closed
AI
75
Atom Investors
Texas
– -$456K -23,899 Closed
1 2
3
4

CLPT Hedge Fund Activity: Q3 2021 in Review

69 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2021, worth a combined $97.5M — down 4.5% from $102M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CLPT and 11 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 24 added.

The largest buyer was Royce & Associates, adding an estimated $9.82M. The largest seller was Parian Global Management, cutting an estimated $9.85M.

  • 69 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2021, down from 76 in Q2 2021.
  • Funds reported $97.5M of ClearPoint Neuro stock for Q3 2021, down 4.5% quarter-over-quarter.
  • 11 funds opened new ClearPoint Neuro positions in Q3 2021 and 17 closed out, a net change of -6 holders.
  • The largest ClearPoint Neuro buyer in Q3 2021 was Royce & Associates, an estimated $9.82M added.
  • The largest ClearPoint Neuro seller in Q3 2021 was Parian Global Management, an estimated $9.85M sold.

Based on aggregated 13F filings for Q3 2021.